Rapid ART — initiating ART as soon as possible after HIV diagnosis — is now endorsed as standard of care in all major antiretroviral guidelines. What are the evidence-based benefits, and for which patient populations is Rapid ART most appropriate? How does it support the treatment as prevention and U = U concepts?
These are some of the questions Dr. Jonathan Colasanti from Atlanta’s Emory University and Grady Health System addresses in this first issue of Volume 7 of eHIV Review.
Nurse Educator – Office Based Addiction Treatment, Training and Technical Assistance Program
Boston Medical Center
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California
Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
1.0 hour Physicians
1.0 contact hour Nurses
Launch date: December 16, 2021
Expiration date: December 15, 2023